Related Experiment Video
Updated: Jan 13, 2026

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
Immunodeficiency in Children With Invasive Pneumococcal Disease
Ahmed M Almesfer1, Mohammed M AlSaiary2, Fahad M Alharbi3
1Department of Pediatrics, Pediatric Allergy and Immunology Unit, Maternity and Children Hospital, Dammam, SAU.
Invasive pneumococcal disease (IPD) in children often signals underlying immune deficiencies. Early identification and tailored management, including vaccines and prophylaxis, can reduce recurrence and prevent severe outcomes.
Area of Science:
- Pediatrics
- Immunology
- Infectious Diseases
Background:
- Invasive pneumococcal disease (IPD) remains a major cause of childhood illness and death, even with vaccination.
- IPD in healthy children can indicate previously unknown immunodeficiencies.
- Understanding immune mechanisms is crucial for preventing IPD.
Purpose of the Study:
- To review immunologic mechanisms predisposing children to IPD.
- To highlight the role of IPD as an indicator of immunodeficiency.
- To inform individualized management strategies for IPD.
Main Methods:
- Narrative review synthesizing evidence from multicenter studies.
- Examination of immunologic mechanisms underlying IPD.
- Analysis of common immune defects (antibody, complement, innate signaling).
Main Results:
- Common defects include antibody/complement deficiencies, congenital asplenia, and innate immune disorders (MYD88, IRAK4).
- Breakthrough infections occur due to non-vaccine serotypes and impaired immune responses.
- Structured post-infection evaluation can identify immune defects early.
Conclusions:
- IPD can be a key indicator of underlying immunodeficiency in children.
- Individualized management optimizing vaccines, prophylaxis, and follow-up is essential.
- Early identification and management decrease IPD recurrence and improve prevention.
More Related Videos
09:12Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
12:21A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
Published on: September 28, 2022
Related Concept Videos
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Pneumonia III: Complications and Assessment
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: